Sue S. Yom

From Innovation to Evidence: The Middle Age of Stereotactic Body Radiotherapie

Generating the Evidence to Support Stereotactic Radiotherapie Evolution: Challenges and a Roadmap for Progress

Global Dose Prescription Variances Exemplified Through Oropharynx Cancer: When Is 70 Gray 70 Gray?